Realities of KRAS-mutated non-small cell lung cancer

DOI QR Code

Min, Young Joo (Division of Oncology, Department of Hematology and Oncology, Ulsan University Hospital)

Matikas A, Mistriotis D, Georgoulias V, Kotsakis A. Targeting KRAS mutated non-small cell lung cancer: a history of failures and a future of hope for a diverse entity. Crit Rev Oncol Hematol 2017;110:1-12. https://doi.org/10.1016/j.critrevonc.2016.12.005
Park S, Kim JY, Lee SH, et al. KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer. Korean J Intern Med 2017;32:514-522. https://doi.org/10.3904/kjim.2015.299